Web Based Renal Transplant Patient Medication Education
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.
| Condition | Intervention | Phase |
|---|---|---|
|
Renal Transplant Recipients |
Behavioral: Internet based education software |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Educational/Counseling/Training |
| Official Title: | Web Based Renal Transplant Patient Medication Education |
- Medication errors
- Serum creatinine
- Rejection episodes
- Rehospitalizations
- Graft loss
| Estimated Enrollment: | 250 |
| Study Start Date: | July 2005 |
| Estimated Study Completion Date: | April 2006 |
Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (<6 months) and established (> 6 months), kidney transplant recipients is proposed.
Eligibility| Ages Eligible for Study: | 14 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:age > 18 or capable of managing own medications
-
Exclusion Criteria:Education level below 10th grade
-
Contacts and Locations| United States, Connecticut | |
| Yale New Haven Hospital | Recruiting |
| New Haven, Connecticut, United States, CT | |
| Contact: Amy L Friedman, MD 203-785-2565 amy.friedman@yale.edu | |
| Principal Investigator: Amy L Friedman, MD | |
| Principal Investigator: | Amy L Friedman, MD | Yale University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00327483 History of Changes |
| Other Study ID Numbers: | RO1-HS15038-03 |
| Study First Received: | May 16, 2006 |
| Last Updated: | May 16, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by Agency for Healthcare Research and Quality (AHRQ):
|
Transplant Medication error Patient Safety Information technology |
ClinicalTrials.gov processed this record on May 19, 2013